Related Experiment Videos

Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes

Jaco Voorham1, Flora M Haaijer-Ruskamp, Ronald P Stolk

  • 1Clinical Pharmacology, University of Groningen, Groningen, The Netherlands. j.voorham@epi.umcg.nl

Diabetes Care
|December 12, 2007
PubMed

Insights

Many patients with type 2 diabetes are undertreated for high blood pressure, cholesterol, and A1C. General practitioners often fail to intensify drug treatment even with poor control, indicating a gap in diabetes risk factor management.

Area of Science:

  • Cardiology
  • Endocrinology
  • General Practice

Background:

  • Undertreatment of modifiable risk factors is prevalent in type 2 diabetes management.
  • Suboptimal control of blood pressure, lipids, and glycemic levels contributes to significant long-term complications.

Purpose of the Study:

  • To evaluate the impact of elevated blood pressure, total cholesterol, and A1C on Dutch general practitioners' decisions regarding drug treatment adjustments.
  • To quantify undertreatment rates in patients with type 2 diabetes and identify factors influencing treatment intensification.

Main Methods:

  • A cohort study involving 3,029 patients with type 2 diabetes over a 1-year period.
  • Analysis of treatment decisions based on blood pressure, total cholesterol, and A1C levels against established guidelines.

Main Results:

  • 58% of patients with poor blood pressure control, 71% with high cholesterol, and 21% with poor glycemic control remained untreated.
  • Among treated patients, 52% did not receive intensified antihypertensive, 81% lipid-lowering, and 43% glucose-lowering medication.
  • Lower intervention rates were observed for moderate versus poor blood pressure control, but not for cholesterol or A1C.

Conclusions:

  • General practitioners demonstrate low rates of treatment intensification for blood pressure and lipid management in type 2 diabetes patients.
  • Current treatment thresholds do not fully explain the observed undertreatment, suggesting other barriers to optimal risk factor management.
  • There is a critical need to improve medication management strategies for cardiovascular and glycemic risk factors in type 2 diabetes.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...